UK-US Trade Deal Could More Than Double NHS Drug Costs, BMJ Analysis Warns

What the Deal Actually Means for the NHS

For anyone who relies on the NHS — and that’s most of us here in Kent — the cost of medicines isn’t just an abstract Treasury concern. It directly shapes which treatments are available, how quickly they reach patients, and what’s left in the budget for everything else. So a new analysis published in the British Medical Journal, one of the world’s most respected medical journals, is raising some serious questions about the UK-US trade deal and what it means for healthcare funding.

The BMJ posted the findings on its official account, summarising the key concern plainly.

According to the BMJ’s analysis, the trade deal on pharmaceuticals will more than double the amount of money the NHS pays for new medicines over the next 11 years. That’s not a modest increase — it’s a fundamental shift in how much public money flows out of NHS budgets and into pharmaceutical pricing agreements shaped, at least in part, by American trade priorities.

Why Pharmaceutical Pricing Is So Complicated

To understand why this matters, it helps to know a little about how the NHS normally buys medicines. In England, a body called the National Institute for Health and Care Excellence — NICE — assesses whether new drugs offer good value for money before the NHS agrees to fund them. This system has historically kept costs lower than in the US, where drug prices are set almost entirely by market forces and can be eye-wateringly high.

Trade deals can put pressure on that system. If the UK agrees to terms that bring its pharmaceutical pricing closer to American norms, the NHS ends up paying more — sometimes far more — for the same medicines.

The BMJ’s Core Argument

The BMJ’s analysis doesn’t just flag the cost increase. It goes a step further, arguing that diverting NHS funds to pay for higher drug prices will be detrimental to population health. In plain English: if more money goes on medicines, less is available for staff, services, hospitals, and the broader care that keeps communities healthy.

That’s a significant claim from a publication that doesn’t tend towards alarm without evidence.

The BMJ is a peer-reviewed journal — meaning its content is checked by independent medical experts before publication. It carries real weight in policy circles.

No Official Response Yet

At the time of writing, no formal response from NHS England, the Department of Health and Social Care, or UK trade negotiators has been attached to this specific analysis. The BMJ’s piece is framed as independent academic commentary rather than government policy — but analyses published there frequently inform public and political debate.

It’s also worth being clear: this is an analysis of projected costs, not a confirmed budget decision. The figures represent what researchers expect to happen over 11 years if the deal proceeds as currently structured.

—

Key Takeaways

• The UK-US trade deal on pharmaceuticals is projected to more than double NHS spending on new medicines over the next 11 years, according to a BMJ analysis
• The BMJ argues that diverting NHS funds toward higher drug costs will be detrimental to population health across the UK
• The analysis is independent academic commentary — no official government or NHS response has been attached to its findings at this stage

What This Means for Kent Residents

For people in Kent — whether you’re a patient waiting on a new treatment, a carer managing a family member’s prescriptions, or simply someone who uses NHS services — any large-scale shift in pharmaceutical spending has the potential to affect what’s available locally. NHS Kent and Medway, the Integrated Care Board responsible for planning and funding health services across the county, operates within national NHS budgets, and pressures at a national level do filter down to regional commissioning decisions over time. If you have concerns about access to medicines or NHS services in your area, your GP surgery is the best first point of contact — or you can call NHS 111 for general health queries. For urgent medical needs, always call 999.